In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Bill Barker about the latest headlines from Wall Street. They discuss what gives Moderna‘s vaccine candidate an edge over Pfizer‘s , and also talk about how the markets reacted to the news. They’ve got a couple of merger and acquisition deals in real estate to discuss, home improvement and banking developments to share, and much more.
To catch full episodes of all The Motley Fool’s free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Where to invest $1,000 right now
Before you consider Moderna, Inc., you’ll want to hear this.
Investing legends and Motley Fool Co-founders David and Tom Gardner just revealed what they believe are the 10 best stocks for investors to buy right now… and Moderna, Inc. wasn’t one of them.
The online investing service they’ve run for nearly two decades, Motley Fool Stock Advisor, has beaten the stock market by over 4X.* And right now, they think there are 10 stocks that are better buys.
